Ifp Advisors, Inc Catalyst Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$11.5 - $18.08 $1,955 - $3,073	170 Added 34.0%	670 $9,000
Q1 2023 Apr 18, 2023	SELL	$14.34 - $21.05 $21,839 - $32,059	-1,523 Reduced 75.28%	500 $8,000
Q4 2022 Feb 07, 2023	SELL	$12.25 - $19.5 $4,606 - $7,332	-376 Reduced 15.67%	2,023 $12,000
Q2 2022 Sep 06, 2022	BUY	$6.23 - $8.57 $14,945 - $20,559	2,399 New	2,399 $9,000
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $14,945 - $20,559	-2,399 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$5.31 - $8.31 $12,738 - $19,935	2,399 New	2,399 $19,000
Q3 2021 Oct 06, 2021	SELL	$4.85 - $6.04 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$4.29 - $6.05 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$3.45 - $4.69 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$2.97 - $3.83 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$2.97 - $5.08 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$3.48 - $5.05 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$2.61 - $5.21 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	SELL	$3.67 - $5.7 $4,859 - $7,546	-1,324 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$3.89 - $7.43 $5,150 - $9,837	1,324 New	1,324 $7,000
Q4 2017 Jan 24, 2018	SELL	$2.51 - $4.4 $2,510 - $4,400	-1,000 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	1,000	1,000 $1,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.